Researchers combine dichloroacetate and metformin with a 10-fold lower Navitoclax dose, selectively clearing senescent cells while limiting platelet toxicity and advancing clinical senolytic use. A ne...
Senolytic drugs restore stem cell function in aged mice, raising hopes for treating sarcopenia and frailty in humans. But safety hurdles remain. Cellular senescence is stealing stem cells’ regen...
A comparative study reveals that dasatinib-quercetin reduces senescence and fibrosis in intervertebral disc degeneration, while navitoclax shows no benefit, highlighting DQ’s potential for affor...
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...